BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patel YC. Molecular pharmacology of somatostatin receptor subtypes. J Endocrinol Invest. 1997;20:348-367. [PMID: 9294784 DOI: 10.1007/bf03350317] [Cited by in Crossref: 185] [Cited by in F6Publishing: 41] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Seidler C, Zegota MM, Raabe M, Kuan SL, Ng DYW, Weil T. Dynamic Core-Shell Bioconjugates for Targeted Protein Delivery and Release. Chem Asian J 2018;13:3474-9. [PMID: 30036452 DOI: 10.1002/asia.201800843] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
2 Harda K, Szabo Z, Juhasz E, Dezso B, Kiss C, Schally AV, Halmos G. Expression of Somatostatin Receptor Subtypes (SSTR-1-SSTR-5) in Pediatric Hematological and Oncological Disorders. Molecules 2020;25:E5775. [PMID: 33297556 DOI: 10.3390/molecules25235775] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Takeuchi K, Endoh T, Hayashi S, Aihara T. Activation of Muscarinic Acetylcholine Receptor Subtype 4 Is Essential for Cholinergic Stimulation of Gastric Acid Secretion: Relation to D Cell/Somatostatin. Front Pharmacol 2016;7:278. [PMID: 27625606 DOI: 10.3389/fphar.2016.00278] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tzotzas T, Papazisis K, Perros P, Krassas GE. Use of somatostatin analogues in obesity. Drugs. 2008;68:1963-1973. [PMID: 18778119 DOI: 10.2165/00003495-200868140-00003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
5 Correale P, Sciandivasci A, Intrivici C, Pascucci A, Del Vecchio MT, Marsili S, Savelli V, Voltolini L, Di Bisceglie M, Guarnieri A, Gotti G, Francini G. Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation. Br J Cancer 2007;96:1343-7. [PMID: 17437022 DOI: 10.1038/sj.bjc.6603734] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
6 Zeitler P, Siriwardana G. Stimulation of mitogen-activated protein kinase pathway in rat somatotrophs by growth hormone-releasing hormone. Endocrine 2000;12:257-64. [PMID: 10963046 DOI: 10.1385/ENDO:12:3:257] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
7 Nagy A, Schally AV, Halmos G, Armatis P, Cai RZ, Csernus V, Kovács M, Koppán M, Szepesházi K, Kahán Z. Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin. Proc Natl Acad Sci U S A 1998;95:1794-9. [PMID: 9465096 DOI: 10.1073/pnas.95.4.1794] [Cited by in Crossref: 101] [Cited by in F6Publishing: 93] [Article Influence: 4.4] [Reference Citation Analysis]
8 Shooli H, Dadgar H, Wáng YJ, Vafaee MS, Kashuk SR, Nemati R, Jafari E, Nabipour I, Gholamrezanezhad A, Assadi M, Larvie M. An update on PET-based molecular imaging in neuro-oncology: challenges and implementation for a precision medicine approach in cancer care. Quant Imaging Med Surg 2019;9:1597-610. [PMID: 31667145 DOI: 10.21037/qims.2019.08.16] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
9 Adriaenssens A, Lam BY, Billing L, Skeffington K, Sewing S, Reimann F, Gribble F. A Transcriptome-Led Exploration of Molecular Mechanisms Regulating Somatostatin-Producing D-Cells in the Gastric Epithelium. Endocrinology 2015;156:3924-36. [PMID: 26241122 DOI: 10.1210/en.2015-1301] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 8.5] [Reference Citation Analysis]
10 Abdellatif AAH, Aldalaen SM, Faisal W, Tawfeek HM. Somatostatin receptors as a new active targeting sites for nanoparticles. Saudi Pharm J 2018;26:1051-9. [PMID: 30416362 DOI: 10.1016/j.jsps.2018.05.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
11 Hirschmann RF, Nicolaou KC, Angeles AR, Chen JS, Smith AB 3rd. The beta-D-glucose scaffold as a beta-turn mimetic. Acc Chem Res 2009;42:1511-20. [PMID: 19624154 DOI: 10.1021/ar900020x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
12 Piqueras L, Martínez V. Role of somatostatin receptors on gastric acid secretion in wild-type and somatostatin receptor type 2 knockout mice. Naunyn Schmiedebergs Arch Pharmacol 2004;370:510-20. [PMID: 15599710 DOI: 10.1007/s00210-004-0992-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
13 Barnett P. Somatostatin and somatostatin receptor physiology. Endocrine. 2003;20:255-264. [PMID: 12721505 DOI: 10.1385/endo:20:3:255] [Cited by in Crossref: 91] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
14 Hohla F, Winder T, Greil R, Rick FG, Block NL, Schally AV. Targeted therapy in advanced metastatic colorectal cancer: Current concepts and perspectives. World J Gastroenterol 2014; 20(20): 6102-6112 [PMID: 24876732 DOI: 10.3748/wjg.v20.i20.6102] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
15 Baumard L, Weerts ZZRM, Masclee AAM, Keszthelyi D, Michael-Titus AT, Peiris M. Effect of Obesity on the Expression of Nutrient Receptors and Satiety Hormones in the Human Colon. Nutrients 2021;13:1271. [PMID: 33924402 DOI: 10.3390/nu13041271] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Barnett P. Somatostatin and somatostatin receptor physiology. Endocrine. 2003;20:255-264. [PMID: 12721505 DOI: 10.1385/ENDO: 20: 3: 255] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Grande E, Díez JJ, Pachón V, Carrato A. Advances in the therapy of gastroenteropancreatic-neuroendocrine tumours (GEP-NETs). Clin Transl Oncol 2010;12:481-92. [PMID: 20615825 DOI: 10.1007/s12094-010-0541-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
18 Gupta MK, Qin RY. Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol 2003; 9(6): 1144-1155 [PMID: 12800214 DOI: 10.3748/wjg.v9.i6.1144] [Cited by in CrossRef: 136] [Cited by in F6Publishing: 123] [Article Influence: 7.6] [Reference Citation Analysis]
19 Piqueras L, Taché Y, Martínez V. Somatostatin receptor type 2 mediates bombesin-induced inhibition of gastric acid secretion in mice. J Physiol 2003;549:889-901. [PMID: 12692184 DOI: 10.1113/jphysiol.2003.039750] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
20 Chin SO, Rhee SY, Chon S, Hwang YC, Jeong IK, Oh S, Kim SW. Investigation of responsiveness to thyrotropin-releasing hormone in growth hormone-producing pituitary adenomas. Int J Endocrinol 2013;2013:159858. [PMID: 24348552 DOI: 10.1155/2013/159858] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
21 Parry JJ, Chen R, Andrews R, Lears KA, Rogers BE. Identification of critical residues involved in ligand binding and G protein signaling in human somatostatin receptor subtype 2. Endocrinology 2012;153:2747-55. [PMID: 22495673 DOI: 10.1210/en.2011-1662] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
22 Paragliola RM, Prete A, Papi G, Torino F, Corsello A, Pontecorvi A, Corsello SM. Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors. Drug Des Devel Ther 2016;10:3459-70. [PMID: 27822010 DOI: 10.2147/DDDT.S76732] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Pisarek H, Stepień T, Kubiak R, Borkowska E, Pawlikowski M. Expression of somatostatin receptor subtypes in human thyroid tumors: the immunohistochemical and molecular biology (RT-PCR) investigation. Thyroid Res 2009;2:1. [PMID: 19173713 DOI: 10.1186/1756-6614-2-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
24 Videau C, Hochgeschwender U, Kreienkamp HJ, Brennan MB, Viollet C, Richter D, Epelbaum J. Characterisation of [125I]-Tyr0DTrp8-somatostatin binding in sst1- to sst4- and SRIF-gene-invalidated mouse brain. Naunyn Schmiedebergs Arch Pharmacol 2003;367:562-71. [PMID: 12759718 DOI: 10.1007/s00210-003-0758-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 2.5] [Reference Citation Analysis]
25 Paragliola RM, Corsello SM, Salvatori R. Somatostatin receptor ligands in acromegaly: clinical response and factors predicting resistance. Pituitary 2017;20:109-15. [PMID: 27778296 DOI: 10.1007/s11102-016-0768-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
26 Wang CH, Tang CW, Liu CL, Tang LP. Inhibitory effect of octreotide on gastric cancer growth via MAPK pathway. World J Gastroenterol 2003; 9(9): 1904-1908 [PMID: 12970873 DOI: 10.3748/wjg.v9.i9.1904] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
27 Ludvigsen E, Stridsberg M, Taylor JE, Culler MD, Oberg K, Janson ET. Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells. Med Oncol 2004;21:285-95. [PMID: 15456957 DOI: 10.1385/MO:21:3:285] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
28 Heidari P, Wehrenberg-Klee E, Habibollahi P, Yokell D, Kulke M, Mahmood U. Free somatostatin receptor fraction predicts the antiproliferative effect of octreotide in a neuroendocrine tumor model: implications for dose optimization. Cancer Res 2013;73:6865-73. [PMID: 24080280 DOI: 10.1158/0008-5472.CAN-13-1199] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
29 Yang L, Berk SC, Rohrer SP, Mosley RT, Guo L, Underwood DJ, Arison BH, Birzin ET, Hayes EC, Mitra SW, Parmar RM, Cheng K, Wu TJ, Butler BS, Foor F, Pasternak A, Pan Y, Silva M, Freidinger RM, Smith RG, Chapman K, Schaeffer JM, Patchett AA. Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2. Proc Natl Acad Sci U S A 1998;95:10836-41. [PMID: 9724791 DOI: 10.1073/pnas.95.18.10836] [Cited by in Crossref: 98] [Cited by in F6Publishing: 88] [Article Influence: 4.3] [Reference Citation Analysis]
30 Farooqi S, Bevan JS, Sheppard MC, Wass JA. The therapeutic value of somatostatin and its analogues. Pituitary 1999;2:79-88. [PMID: 11081176 DOI: 10.1023/a:1009978106476] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
31 Gut P, Fischbach J, Kamiński G, Ruchała M. Contemporary methods of therapy and follow-up of neuroendocrine tumours of the gastrointestinal tract and the pancreas. Contemp Oncol (Pozn) 2012;16:371-5. [PMID: 23788913 DOI: 10.5114/wo.2012.31764] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
32 Volante M, Bozzalla-Cassione F, Papotti M. Somato-statin receptors and their interest in diagnostic pathology. Endocr Pathol. 2004;15:275-291. [PMID: 15681851 DOI: 10.1385/EP:15:4:275] [Cited by in Crossref: 28] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
33 Danoff A, Kleinberg D. Somatostatin analogs as primary medical therapy for acromegaly. Endocrine 2003;20:291-7. [PMID: 12721510 DOI: 10.1385/ENDO:20:3:291] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Kumar U. Cross-talk and modulation of signaling between somatostatin and growth factor receptors. Endocrine 2011;40:168-80. [PMID: 21870170 DOI: 10.1007/s12020-011-9524-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
35 Kiseljak-Vassiliades K, Xu M, Mills TS, Smith EE, Silveira LJ, Lillehei KO, Kerr JM, Kleinschmidt-DeMasters BK, Wierman ME. Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors. Mol Cell Endocrinol 2015;417:73-83. [PMID: 26391562 DOI: 10.1016/j.mce.2015.09.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
36 Danalev D, Borisova D, Yaneva S, Georgieva M, Balacheva A, Dzimbova T, Iliev I, Pajpanova T, Zaharieva Z, Givechev I, Naydenova E. Synthesis, in vitro biological activity, hydrolytic stability and docking of new analogs of BIM-23052 containing halogenated amino acids. Amino Acids 2020;52:1581-92. [PMID: 33215308 DOI: 10.1007/s00726-020-02915-3] [Reference Citation Analysis]
37 Rivera JA, Alturaihi H, Kumar U. Differential regulation of somatostatin receptors 1 and 2 mRNA and protein expression by tamoxifen and estradiol in breast cancer cells. J Carcinog 2005;4:10. [PMID: 16018813 DOI: 10.1186/1477-3163-4-10] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
38 Paragliola RM, Salvatori R. Novel Somatostatin Receptor Ligands Therapies for Acromegaly. Front Endocrinol (Lausanne) 2018;9:78. [PMID: 29563895 DOI: 10.3389/fendo.2018.00078] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
39 Deghenghi R. Synthetic peptides and their non-peptidyl mimetics in endocrinology: from synthesis to clinical perspectives. J Endocrinol Invest 1998;21:787-93. [PMID: 9972682 DOI: 10.1007/BF03348048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
40 Thodou E, Kontogeorgos G, Theodossiou D, Pateraki M. Mapping of somatostatin receptor types in GH or/and PRL producing pituitary adenomas. J Clin Pathol 2006;59:274-9. [PMID: 16505278 DOI: 10.1136/jcp.2005.026914] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
41 Talme T, Ivanoff J, Hägglund M, Van Neerven RJ, Ivanoff A, Sundqvist KG. Somatostatin receptor (SSTR) expression and function in normal and leukaemic T-cells. Evidence for selective effects on adhesion to extracellular matrix components via SSTR2 and/or 3. Clin Exp Immunol 2001;125:71-9. [PMID: 11472428 DOI: 10.1046/j.1365-2249.2001.01577.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]